GGrantIndex
Sort

17,828 grants matching crispr

Diagnostic Innovations for Pediatric Tuberculosis in Bolivia

$751,006
Richard A Oberhelman · Tulane University Of Louisiana · R01 · FY2023 · AI

Resources for Comparative Mendelian Disease Genomics

$750,849
Laura G Reinholdt · Jackson Laboratory · R24 · FY2023 · OD

Pharmacogenomic discovery of therapeutic targets for corrector-refractory cystic fibrosis

$750,672
Ron R Kopito · Stanford University · R01 · FY2025 · HL

Omics, mice and men: Development of precision transfusion medicine

$750,647
Mark Thomas Gladwin · University Of Maryland Baltimore · R01 · FY2024 · HL

High-throughput functional characterization of human enhancers

$750,521
John T Lis · Cornell University · UM1 · FY2020 · HG

High-throughput functional characterization of human enhancers

$750,521
John T Lis · Cornell University · UM1 · FY2019 · HG

Mechanisms of gene-environment interaction in developmental lead exposure leading to Alzheimer's disease phenotypes

$750,493
Jennifer L. Freeman · Purdue University · R01 · FY2025 · NS

Mechanisms of gene-environment interaction in developmental lead exposure leading to Alzheimer's disease phenotypes

$750,493
Jennifer L. Freeman · Purdue University · R01 · FY2024 · NS

Mechanisms of gene-environment interaction in developmental lead exposure leading to Alzheimer's disease phenotypes

$750,493
Jennifer L. Freeman · Purdue University · R01 · FY2023 · NS

Enabling Nanoplatforms for Targeted in vivo Delivery of CRISPR/Cas9 Ribonucleoproteins in the Brain

$750,461
Shaoqin - Gong · University Of Wisconsin-Madison · UG3 · FY2019 · NS

Enabling Nanoplatforms for Targeted in vivo Delivery of CRISPR/Cas9 Ribonucleoproteins in the Brain

$750,461
Shaoqin - Gong · University Of Wisconsin-Madison · UG3 · FY2020 · NS

Inherited colorectal cancer risk variants: from association to biology

$750,187
Graham Casey · University Of Virginia · R01 · FY2019 · CA

Collaborative Research: Ideas Lab: Rational Design of Noncoding RNA for Epigenetic Signal Amplification

$750,032
Alisha N Jones · New York University · · FY2023 · BIO

Critical role for Solute Carrier Proteins (SLCs) for mast cell function

$750,025
Adrian M Piliponsky · Seattle Children'S Hospital · R01 · FY2023 · AI

RUI: Genetic approaches to uncover mechanisms governing seasonal reproductive development in Physcomitrium patens

$750,000
Karen A Hicks · Kenyon College · · FY2025 · BIO

Transition: Metabolomics-driven understanding of rules that coordinate metabolic responses and adaptive evolution of synthetic biology chassis

$750,000
Yinjie Tang · Washington University · · FY2023 · BIO

Elucidating the Role of Extracellular Polyphosphate in Mycobacterium tuberculosis Antibiotic Tolerance.

$750,000
Ramesh Rijal · University Of Southern Mississippi · R16 · FY2025 · AI

Toward a Complete Set of Germline Null and Modifiable Mutations in Drosophila

$749,865
Ming Fa · Genetivision Corporation · R44 · FY2018 · GM

Toward a Complete Set of Germline Null and Modifiable Mutations in Drosophila

$749,865
Ming Fa · Genetivision Corporation · R44 · FY2017 · GM

Deciphering the function and mechanisms of lncRNA-mediated organization of nuclear compartments

$749,623
Mitchell Guttman · California Institute Of Technology · U01 · FY2018 · DA

Deciphering the function and mechanisms of lncRNA-mediated organization of nuclear compartments

$749,623
Mitchell Guttman · California Institute Of Technology · U01 · FY2016 · DA

Deciphering the function and mechanisms of lncRNA-mediated organization of nuclear compartments

$749,623
Mitchell Guttman · California Institute Of Technology · U01 · FY2017 · DA

Deciphering the function and mechanisms of lncRNA-mediated organization of nuclear compartments

$749,623
Mitchell Guttman · California Institute Of Technology · U01 · FY2019 · DA

Deciphering the function and mechanisms of lncRNA-mediated organization of nuclear compartments

$749,622
Mitchell Guttman · California Institute Of Technology · U01 · FY2015 · DA

A nanoparticle delivery system for CRISPR/Cas9 based therapeutics

$749,563
Peter X Ma · Atgc, Inc. · R42 · FY2018 · TR